Health Update Bahamas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Update Bahamas.

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Press releases published on December 15, 2025

December 15, 2025

U.S. Court of Appeals Affirms Novarad’s ’807 Patent as Company Continues to Defend Leadership in Augmented Reality Surgical Navigation

GlobeNewswire

December 15, 2025

New research in ONCOLOGY® identifies gaps between gynecologic cancer disease burden and clinical trial availability at UCLA Jonsson Comprehensive Cancer Center

GlobeNewswire

December 15, 2025

Oncotelic Therapeutics and Brush and Key Foundation Announce Publication in International Journal of Molecular Sciences Highlighting Context-Dependent Biomarkers in Liver and Pancreatic Cancer

GlobeNewswire

December 15, 2025

TRIMEDX launches TRIMEDX-AIQ™, an AI-native clinical asset intelligence offering built on the industry’s most extensive repository of medical device data

GlobeNewswire

December 15, 2025

Global Gene Therapy Market to Surge to USD 36.55 Billion by 2032 | MarketsandMarkets™

GlobeNewswire

December 15, 2025

Trinity Biotech Expands Global Rollout of High-Capacity Column System for FDA-Cleared HbA1c Testing Solution After Securing Regulatory Clearances

GlobeNewswire

December 15, 2025

BetaGlue Therapeutics Receives Belgium Ministry of Health Approval for YntraDose Clinical Trial in Unresectable Locally Advanced Pancreatic Cancer (uLA-PDAC)

GlobeNewswire

December 15, 2025

BetaGlue Therapeutics erhält Genehmigung des belgischen Gesundheitsministeriums für klinische Studie mit YntraDose bei inoperablem lokal fortgeschrittenem Bauchspeicheldrüsenkrebs (uLA-PDAC)

GlobeNewswire

December 15, 2025

NeOnc Technologies Reports Updated Clinical Results

GlobeNewswire

December 15, 2025

Actuate Therapeutics Announces Publication of Positive Phase II Clinical Data for Elraglusib Combined with Platinum Chemotherapy and Sequential Immunotherapy in Recurrent, Metastatic Salivary Gland Carcinoma

GlobeNewswire

December 15, 2025

Noom Enters Longevity Health Space with Proactive Health Microdose GLP-1Rx Program Designed to Help Millions Address the Biomarkers Most Linked to Future Disease

GlobeNewswire

December 15, 2025

ORYZON Announces the Voting Results of December 2025 Extraordinary General Shareholders' Meeting

GlobeNewswire

December 15, 2025

PharmAla Biotech Australia Contracts with UK-based CDMO for Manufacture of ALA-002 Drug Substance

GlobeNewswire

December 15, 2025

NetraMark Achieves Major FDA Milestone

GlobeNewswire

December 15, 2025

OKYO Pharma Announces Chairman and Founder Acquires Shares

GlobeNewswire

December 15, 2025

Inspira Announces $1.8 Million Registered Direct Offering Priced At-The-Market and Additional Equity Financing Agreement to Support Ongoing Commercial Execution

GlobeNewswire

December 15, 2025

Sienna Announces December Dividend

GlobeNewswire

December 15, 2025

FOXO TECHNOLOGIES INC. CEO SEAMUS LAGAN PROVIDES YEAR-END REVIEW TO SHAREHOLDERS

GlobeNewswire

December 15, 2025

Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

December 15, 2025

Seismic Therapeutic to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 15, 2026

GlobeNewswire